Semaglutide is a GLP-1 receptor agonist (the same class as Wegovy and Ozempic) and tirzepatide is a dual GLP-1 and GIP receptor agonist (the class behind Mounjaro and Zepbound)
Total RNA was converted into complementary DNA (cDNA) using the Invitrogen SuperScript IV One-Step RT-PCR kit (Cat# 12594100, Thermo Fisher Scientific, Waltham, MA, USA)
Artificial intelligence enables quantitative assessment of ulcerative colitis histology
Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose)
These injections contain higher amounts of the natural GLP-1 hormone, which makes the person feel full, his stomach is full most of the time, and eats much less than before, and this helps in losing weight